Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336

Rankning i aktier #3772
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Aktiekurs
$4.87
Marknadsvärde
$4.36B
Förändring (1 dag)
-5.47%
Förändring (1 år)
-15.62%
Land
CN
Handel Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

Kategori

Healthcare
Utdelningshistorik för Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (aktiens symbol: 688336) har gjort totalt 5 utdelningsbetalningar.
Summan av alla utdelningar (justerat för aktiesplitar) är: $0.63
Utdelningsavkastning (TTM): 0.0149
Utdelningsbetalningar för Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336) från 2024 till 2026
Årliga utdelningsbetalningar
År Utdelning (justerat för aktiesplitar) Ändra
2026 (TTM) $0.45 265.85%
2025 $0.123 114.66%
2024 $0.0573 0.00%
Lista över alla utdelningsbetalningar
År Utdelning Ändra
2026 (TTM) $0.6525 265.75%
2025 $0.1784 114.94%
2024 $0.083 0.00%
Utdelningar för liknande företag eller konkurrenter
Företag Antal utdelningsbetalningar Land
0.00%
US
0.00%
US
67.00%
AU
30.00%
BE
0.00%
NL